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In Brief
Mertins et al. develop a systematic
framework to unify the study of signaling
and transcriptional regulatory networks.
By integrating physical, enzymatic, and
functional interaction data, they identify
biochemical paths that connect Toll-like
receptor (TLR) 4 signaling to
transcription. Their analysis uncovers two
dozen regulators in TLR signaling,
including AP1AR and PICALM, which link
vesicle transport to pro-inflammatory
responses.
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Building an integrated view of cellular responses to
environmental cues remains a fundamental chal-
lenge due to the complexity of intracellular networks
in mammalian cells. Here, we introduce an integra-
tive biochemical and genetic framework to dissect
signal transduction events using multiple data types
and, in particular, to unify signaling and transcrip-
tional networks. Using the Toll-like receptor (TLR)
system as a model cellular response, we generate
multifaceted datasets on physical, enzymatic, and
functional interactions and integrate these data to
reveal biochemical paths that connect TLR4
signaling to transcription. We define the roles of
proximal TLR4 kinases, identify and functionally
test two dozen candidate regulators, and demon-
strate a role for Ap1ar (encoding the Gadkin protein)
and its binding partner, Picalm, potentially linking
vesicle transport with pro-inflammatory responses.
Our study thus demonstrates how deciphering dy-
namic cellular responses by integrating datasets on
various regulatory layers defines key components
and higher-order logic underlying signaling-to-tran-
scription pathways.
INTRODUCTION
Signaling networks must coordinate multiple layers of regulation
throughout the cell to respond to environmental changes. ForCell
This is an open access article under the CC BY-Nexample, mammalian immune cells detect microbial molecules
thanks to pathogen-sensing pathways such as Toll-like recep-
tors (TLRs) (Takeuchi and Akira, 2010). Upon activation by their
cognate ligands, TLRs follow general principles of signal trans-
duction by recruiting cytosolic adaptors and downstream en-
zymes such as kinases, which triggers cascades of biochemical
changes leading to cellular outputs such as gene expression
changes (Figures 1A and 1B). A fundamental question in cellular
response systems, such as TLRs, is how to generate and
combine knowledge about signaling and transcription regulatory
networks to build an integrated view of the flow of information in
a cell. Answering this question will help close gaps in our knowl-
edge of intracellular wiring and inform therapeutic targeting of
cellular components that are central to disease.
Despite recent advances in measuring cellular processes
and associated biochemical changes frommany different angles
(e.g., post-translational modifications, gene expression, and
transcription factor binding), building integrated models of
signaling pathways that take into account multiple regulatory
layers remains an elusive task due to several challenges. First,
using prior knowledge from databases alone, it is hard to
compare and connect signaling nodes and processes that
have been studied in disparate systems and with different read-
outs. Furthermore, existing databases are largely incomplete, as
demonstrated by the fact that the vast majority of known phos-
phorylation sites remain orphans with respect to their matching
kinases. Second, acquiring data within a single cellular context
and across regulatory processes ranging from post-translational
modifications (PTMs) to protein complexes to kinase substrates
is difficult due to the various technical requirements of each
assay, making them hard to adapt within a unique and relevant
cellular context. Third, individual large-scale measurements areReports 19, 2853–2866, June 27, 2017 ª 2017 The Author(s). 2853
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Figure 1. TLR4 Stimulation with LPS Leads to Global and Dynamic Changes in the Phosphoproteome of DCs
(A and B) Diagram highlighting general principles of cellular signaling-to-transcription events (A) and their transposition to the TLR4 pathway (B).
(C) Temporal changes in the phosphoproteome of LPS-stimulated DCs. Shown are the distributions of log2 fold changes of phosphosites (x axis) between LPS-
treated and untreated cells at indicated times after LPS stimulation, as density (top of each panel) and dot plots (bottom of each panel, withMS2 spectra count in y
axis and showing phosphosites measured in all eight time points).
(D) Comparison between the phosphoproteome and total proteome of LPS-stimulated DCs. Shown are distributions of log2 fold changes of phosphosites (x axis)
and proteins (y axis) between LPS-treated and untreated cells at 120 (top) and 360 (bottom) min post-stimulation.
See also Figure S1 and Table S1.inherently limited by their variability in sensitivity and specificity
and are often used to capture static snapshots rather than the
dynamic events of cellular responses. It is thus critical to address
these challenges to help to dissect the connections that form the
basis of multi-layered cellular responses (Bensimon et al., 2012;
Santra et al., 2014; Yugi et al., 2016).
Here, we hypothesized that integrating measurements
spanning, in the context of a single cellular response model,
both signaling and transcriptional regulatory layers will help to
reveal key network-wide properties that would otherwise not2854 Cell Reports 19, 2853–2866, June 27, 2017be observable. To test this, building upon prior work (Chevrier
et al., 2011), we developed an experimental and computational
framework to measure and integrate the information underlying
signaling-to-transcription events in the TLR system, from the
membrane to gene regulation. We measure dynamic changes
in two types of interactions: physical (i.e., phosphorylation, ki-
nase-substrate relationships, protein-protein and DNA-protein
interactions) and functional (i.e., effects of genetic perturbations
on gene expression or phosphorylation events) (Figure S1A). Us-
ing these datasets, we identify regulators of TLR4 responses in
dendritic cells (DCs), including AP1AR and its binding partner,
PICALM, and introduce a network-based computational
approach that takes advantage of these diverse measurements
to decipher the higher-order logic governing TLR signaling-to-
transcription events.
RESULTS
The Dynamic Phosphoproteome of LPS-Stimulated
Dendritic Cells
We reasoned that large-scale, dynamic measurements of the
changes in protein phosphorylation in lipopolysaccharide
(LPS)-treated DCs would help to reconstruct signaling-to-tran-
scription pathways, because TLR signaling functions through
phosphorylation of its own constituents, from kinases such as
mitogen-activated protein kinases (MAPKs), IRAKs, IKKs, or
TBK1 to transcription factors such as nuclear factor kB
(NF-kB) or IRFs (Figure 1B) (Takeuchi and Akira, 2010). Further-
more, work by others (Sharma et al., 2010; Sjoelund et al., 2014;
Weintz et al., 2010) and us (Chevrier et al., 2011) showed that
phosphoproteomics can identify regulators of the TLR system.
We used stable isotope labeling with amino acids in cell culture
(SILAC)-based phosphoproteomics to compare the levels of
phospho-serine, phospho-threonine, and phospho-tyrosine
sites between DCs left untreated as control or stimulated with
LPS at eight time points (15, 30, 45, 60, 120, 180, 240, and
360 min) (Figures S1B and S1C). We identified and quantified a
total of 20,975 phosphosites derived from 5,789 distinct proteins
in at least two LPS-stimulated samples (false discovery rate
[FDR] < 1%; Figure 1C; Table S1), of which 20.5% were present
in all eight time points (4,310/20,975 phosphosites from 1,952
proteins; Figure S1D) due to undersampling of highly complex
and low-signal-intensity phosphopeptide mixtures in individual
SILAC experiments. The largest changes in the DC phosphopro-
teome were observed at 30 and 45 min after LPS stimulation,
which covered 92.8% of all quantified phosphosites in this study
(19,456/20,795) (Figure S1E). In addition, these changes in phos-
phorylation were not due to changes in protein amounts, as only
0.65 and 1.81% of proteins showed an increase in both phos-
phorylation and protein levels at 2 and 6 hr after LPS stimulation,
respectively (Figure 1D). These results suggested that LPS stim-
ulation modifies a large fraction of the DC phosphoproteome
within an hour.
Temporal Analysis of Phosphorylation Changes
Highlights Known and Candidate Regulators of TLR4
Signaling
Next, to study the dynamics of the LPS-regulated phosphopro-
teome, we focused on the 3,557 phosphosites mapping onto
1,606 proteins that were quantified in at least six out of eight
time points and differentially regulated upon LPS stimulation in
a single or two consecutive time points (2,071/3,557 phospho-
sites for the latter) (Table S2). Overall, 53.4% (3,557/6,659) of
the phosphosites quantified in at least six independent time
points were found to be differentially regulated by LPS, which
corresponds to 61.4% (1,606/2,617) at the phosphoprotein
level. We used k-means clustering to partition these 3,557 phos-
phosites into ten co-abundance clusters with distinct temporalprofiles (Figures 2A and S2A). We found three general patterns
of changes in phosphorylation levels: (1) early upregulation until
45 min (clusters I and II), (2) late upregulation after 120 min (clus-
ter III), and (3) downregulation at various times (clusters IV–X)
(Figure 2B). Each temporal cluster contained known TLR
pathway proteins for a total of 43 out of 141 canonical TLR
components, including 7.8% (11/141) and 10.6% (15/141) for
clusters I and II, respectively (Figures 2B and S2B). Known
TLR proteins identified in this data encompassed both positive
(e.g., MAPK family, IRF3, and NF-kB) and negative (e.g., TANK
and TNFAIP3) regulators, and were differentially phosphory-
lated at multiple sites in some cases (Figure S2C). The 1,606
phosphoproteins present in these ten temporal clusters were
enriched for molecular functions, including kinases, transcrip-
tional regulators, or protein binding (Figure S2D). Some of the
enriched gene sets pointed to nascent areas of TLR biology,
such as the organization and regulation of the TLR systemwithin
the framework of intracellular organelles and structures (e.g.,
activity and regulation of GTPases, cytoskeleton; Figure S2D).
Cluster II, and to a lesser extent other clusters, showed a signif-
icant enrichment for other immune signaling pathways (e.g., B
and T cell receptor signaling or DNA-sensing pathways), high-
lighting the existence of shared proteins between these immune
response systems (Figure S2D). Taken together, these results
reveal the dynamic changes imparted on the DC phosphopro-
teome by LPS, which include known and putative regulators of
TLR4 signaling as well as processes linked to DC biology,
such as changes in cell shape, motility, metabolism, and antigen
processing.
Genetic Perturbations of Phosphorylated Proteins
Identify Putative Regulators of TLR4 Signaling
To test if the phosphoproteins identified above play a role in the
TLR system, we used our temporal and enrichment analyses to
prioritize candidates for genetic perturbations (Figure 3A). We
focused on 751 phosphoproteins from the 1,606 ones used for
temporal clustering, which were upregulated at 30 and 45min af-
ter LPS treatment (clusters I and II; Figure 2B). We reasoned that
using early clusters would help to identify candidate regulators
likely to be downstream of TLR4 by avoiding feedbacks from
transcription or autocrine and paracrine signaling. Third, we
selected 169 out of 751 phosphoproteins to test by retaining
all enzymes (e.g., kinases and GTPases) and enzyme binders
and regulators (e.g., GTPase regulators) (Figures S3A and S3B;
Table S3). All selected phosphoproteins were also found to be
expressed at the mRNA level in DCs (Garber et al., 2012). The
two TLR4 adaptor proteins MYD88 and TRIF (encoded by
Ticam1) were part of these candidate genes. MYD88 was added
manually as a positive control, although it was not found to be
differentially phosphorylated, whereas TRIF matched our selec-
tion criteria above.
We successfully perturbed 131 out of 168 candidate genes
with an average knockdown efficiency of 81% ± 9% SD (Fig-
ure S3C). We stimulated DCs with LPS and measured the effect
of gene silencing on the mRNA levels of 263 TLR response
signature genes, representing the inflammatory and antiviral
programs (Table S3). We determined statistically significant
changes in the expression of signature transcripts uponCell Reports 19, 2853–2866, June 27, 2017 2855
A B
Ph
os
ph
os
ite
s
Figure 2. Temporal Analysis of the LPS-Induced Phosphoproteome Reveals Known and Candidate Regulators of TLR4 Signaling
(A) Temporal phosphorylation profiles during LPS stimulation in DCs. Log2 fold changes between LPS-treated and untreated cells for 3,557 phosphosites (rows)
detected in at least six out of eight time points (columns). Phosphosites are partitioned into ten clusters using k-means (color bars, right). White indicates missing
values.
(B) Median log2 fold changes between LPS-treated and untreated cells (y axis) and median absolute deviation (MAD; colored error bar) at each time point (x axis)
for phosphosites in all ten k-means clusters from (A). Known TLR pathway proteins detected in each cluster are indicated on the right. Parentheses indicate the
number of phosphosites per proteins (when >1).
See also Figure S2 and Table S2.individual knockdowns based on comparisons to 16 control
genes, whose expression remains unchanged upon TLR activa-
tion, and to 38 control short hairpin RNAs (shRNAs) that did not
affect TLR signature genes. 27 out of the 131 genes tested
significantly affected TLR signature gene expression, which
included known TLR signaling components such as TICAM1,
TBK1, MAPK9, RIPK3, and IRAK2 (Figure 3B). Furthermore,
several phosphoproteins were reported to function in TLR
signaling by independent studies: TRAFD1 (Sanada et al.,
2008), STK3 (Geng et al., 2015), ULK1 (Eriksen et al., 2015),
and CORO1A (Tanigawa et al., 2009). Interestingly, known
and candidate components had similar effects on the TLR
gene signature upon knockdown. By measuring the pairwise
similarity among these 27 perturbation profiles (using Pearson’s
correlation), we observed three major modules of signaling reg-
ulators: MYD88 and a set of four proteins (SAMHD1, TBC1D17,
AP1AR, and PDLIM7) affecting inflammatory gene expression
(module I), TICAM1 and five proteins (module II), and 16 proteins
displaying effects that overlap with MYD88 and/or TICAM1
(module III) (Figure 3B).2856 Cell Reports 19, 2853–2866, June 27, 2017Validation of AP1AR and Other Candidate Regulators of
the Myd88-Dependent Inflammatory Pathway
We next sought to validate the putative roles of the four phos-
phoproteins (AP1AR, PDLIM7, SAMHD1, and TBC1D17) whose
perturbation profiles closely resembled that ofMYD88 in control-
ling pro-inflammatory genes (Figure 4A). We measured the
expression levels of inflammatory and antiviral cytokines in
LPS-stimulated DCs infected by two independent, gene-specific
lentiviral shRNAs per candidate phosphoprotein. We observed a
decrease in inflammatory cytokine mRNA expression compared
to eight control hairpins in all cases (Il6, Cxcl1, and, to a lesser
extent, Tnf), whereas antiviral cytokines Ifit1 and Cxcl10 were
mostly unaffected (Figure 4B). Similarly, using mouse Ap1ar/
knockout DCs (Maritzen et al., 2012), we observed a strong
decrease in inflammatory cytokines, especially Il1b, Il12b, and
Tnf, whereas antiviral cytokines were not affected (Ifnb1) or
slightly reduced (Cxcl10) (Figure 4C).
To generate mechanistic insights about the putative role of
AP1AR in the TLR4 pathway, we sought to identify binding part-
ners of AP1AR in LPS-stimulated DCs using affinity purification
AB
Figure 3. Genetic Perturbations of Phos-
phorylated Proteins Identify Putative Regu-
lators of TLR4 Signaling
(A) Overview of phosphoprotein candidate selec-
tion for functional analysis.
(B) Perturbation profiles of the 27 phosphoproteins
that significantly impacted TLR4 outputs. Shown
are the perturbed candidates and control phos-
phoproteins (columns) and the log2 fold changes
for each target gene (rows) between gene-specific
and control shRNAs. The rightmost column cate-
gorizes target genes into antiviral (light green) and
inflammatory (light orange) programs.
See also Figure S3 and Table S3.
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Figure 4. Identification of Candidate Regulators in the MYD88-Dependent Inflammatory Pathway
(A) Perturbation profiles of genes affecting the MYD88 pathway. Shown are four perturbed candidate genes and MYD88 (columns) and the log2 fold changes
between gene-specific and control shRNAs (rows) of ten target genes. The rightmost column categorizes target genes into antiviral (light green) and inflammatory
(light orange) programs.
(B) Expression levels (qPCR) relative to control shRNAs (left bars, dark gray) for two antiviral cytokines (Ifit1 and Cxcl10) and three inflammatory cytokines (Il6,
Cxcl1, and Tnf) following LPS stimulation in DCs using two independent shRNAs. Bottom tick marks separate shRNAs controls and each gene (average indicates
the mean value for all eight control shRNAs). Two to three replicates for each experiment; error bars represent SD.
(legend continued on next page)
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followed by mass spectrometry in primary mouse DCs (Fig-
ure S4A). Protein overexpression was effective in nearly all trans-
duced cells asmeasured byGFP fluorescence anddid not impact
cell responsiveness to LPS, as shown by strong morphological
changes (Figure S4B). We overexpressed V5-tagged AP1AR
and GFP as control bait in SILAC-labeled DCs stimulated with
LPS for 30min (Figure S4C), which led to the identification of pro-
teins that co-precipitatedwithAP1AR, but notGFP (Figure4D;Ta-
ble S4). Several knowncomponents of the assembly protein com-
plex 2 (AP-2) were pulled down with AP1AR (AP2A1, AP2B1, and
AP2S1), as well as the AP-2 binding partner PICALM, which is an
important component of clathrin-mediated endocytosis (Miller
et al., 2015). Next, to test if some of these AP1AR binders affect
TLR4 signaling outputs, we turned back to genetic perturbations
followed by gene signature measurements. Out of ten putative
AP1AR binders (at least two peptides identified and >1.5 log2
SILAC ratio of AP1AR/GFP), six showed a knockdown efficiency
>50%. We found that PICALM led to a decrease in the induction
of LPS-induced inflammatory genes similarly to MYD88, TIRAP,
andAP1AR (Figure 4E). Altogether, these results suggest a poten-
tial mechanism whereby AP1AR and PICALM act together in the
regulation of MYD88-dependent inflammatory signaling.
For another candidate identified based on phosphorylation
changes, SAMHD1, we further tested its potential involvement
in TLR signaling using human skin fibroblasts derived from
Aicardi-Goutie`res syndrome (AGS) patients that carry deleterious
SAMHD1 mutations (Crow and Manel, 2015). We observed a
decrease in both inflammatory and antiviral gene expression
upon LPS stimulation in two independent patient cell lines
compared to three healthy controls (Figure 4F), which differed
fromknockoutmouseDCdata (FigureS4D). The latterobservation
might be attributable to the difference in cellular context or to
compensatorymechanisms in themouse knockout cells. Interest-
ingly, physical interactions between SAMHD1 and TLR pathway
proteins have been reported previously, such as the TLR4adaptor
protein TIRAP (Li et al., 2011), and also with CCNA2 and CDK2,
which can be activated by TLR4 signaling (Hasan et al., 2007;
Huttlin et al., 2015). Altogether, we gathered evidence supporting
that AP1AR, its binding partner PICALM, and SAMHD1 are likely
to act as regulators of pro-inflammatory TLR4 signaling.
Signaling Regulator Perturbation Profiles Overlap with
Transcription Factor Target Genes, Suggesting
Potential Signaling-to-Transcription Paths
Having shown that phosphorylation dynamics can help identify
potential regulators of TLR signaling-to-transcription events,
we next sought to identify how signaling regulators are con-(C) Inhibition of transcription of inflammation cytokines in Ap1ar/ DCs. mRNA
antiviral (light green) cytokines in three replicates per time point. Error bars repre
(D) Interaction proteomics identified putative binders for AP1AR in DCs. Log2 fold
tagged-AP1AR and -GFP (control bait) plotted against the number of peptides id
(E) Perturbation profiles of indicated genes (columns) and the log2 fold changes
rightmost column categorizes target genes into antiviral (light green) and inflamm
(F) Impact of SAMHD1mutations on human fibroblast cell response to LPS. Huma
c.445C > T p.Gln149* for M1 and c.1609-1G > C for M2) were stimulated with L
antiviral (light green) cytokine levels were measured by qPCR (relative to GAPDH
See also Figure S4 and Table S4.nected to downstream transcriptional regulators. The two tar-
geted screens for candidate (1) phosphoproteins and (2)
AP1AR binders led to 29 perturbation profiles showing signifi-
cant changes in TLR signature genes upon LPS stimulation
(Figures 3B and 4E). Based on the similarity of these perturba-
tion-induced expression profiles (Pearson’s correlation), we par-
titioned these 29 proteins into three modules (Figure 5A; similar
to Figure 3B). Next, we asked what transcription factors (TFs)
are likely to act downstream of these three modules of proteins
by taking advantage of existing data on the binding sites across
the genome of 23 TFs involved in TLR4 signaling (Garber et al.,
2012). We reasoned that measuring the overlaps between genes
whose promoters are bound by a TF, and genes whose mRNA
levels are impacted by knockdown of a phosphoprotein, would
help to infer some of the signaling regulator-TF relationships
likely to be active upon TLR4 activation (Figure S5). For 20 out
of 23 TFs tested, we identified significant overlaps (p value <
0.05; hypergeometric test) between gene sets whose promoters
were bound by one or several TFs and those whosemRNA levels
were impacted by knockdown of 25 out of 29 candidate and
known regulators (Figure 5B; Table S5). Some of these overlaps
recapitulated known signaling regulator-TF relationships in the
TLR pathways, such as MYD88 and NF-kB family members
REL and RELB, or TRIF and IRFs and STATs. Gene targets of
AP1AR, MYD88, and PICALM overlapped significantly with
genes bound by RUNX1 and REL. Taken together, these results
further support a role for the 29 phosphoproteins identified
downstream of TLR4 and suggest the existence of signaling
regulator-TF relationships between 25 phosphoproteins and
20 TFs.
Physical and Functional Proteomics Pinpoint Binding
and Phosphorylation Events Downstream of the Myd88
Adaptor and Associate Kinases
Next, to decipher the biochemical events linking the signaling to
transcriptional regulator relationships identified above, we
measured protein-protein and kinase-substrate interactions by
focusing on MYD88-dependent signaling. First, in DCs stimu-
lated with LPS for 30 min, we rediscovered most known
MYD88 binding partners, including TIRAP, TRAF6, or IRAK fam-
ily kinases, which support the validity of our affinity-purification
coupled with mass spectrometry (AP-MS) assay in primary
DCs (Figures 6A and S6A; Table S6). IRAK2 immunoprecipitation
identified several interaction partners such as MYD88 and
TRAF6 but with lower enrichment ratios compared to MYD88,
which is likely due to the short-lived interaction dynamics of ki-
nases (Figure 6B).levels (qPCR; relative to Gapdh) for indicated inflammatory (light orange) and
sent SD.
change (x axis) of proteins enriched differentially between DCs expressing V5-
entified per protein (y axis).
between gene-specific and control shRNAs (rows) of 150 target genes. The
atory (light orange) programs.
n fibroblasts from healthy (H) or mutant-carrying patients (M; with homozygous
PS or left untreated as control, and indicated inflammatory (light orange) and
). Error bars represent SD.
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Figure 5. Similarities in Perturbation Profiles and Overlap with TF Target Genes Suggest Three Functional Modules for the 29 Candidate
Phosphoproteins
(A) Functional classification based on similarity of perturbation profiles. Shown is a correlation matrix (Pearson correlation coefficient) of the perturbation profiles
from Figures 3B and 4E combined.
(B) Intersection between genes affected by a phosphoprotein perturbation and genes whose promoters are bound by transcription factors (TFs). Shown are the
overlaps between genes affected by 29 candidate signaling regulators knockdowns (columns, including positive control genes) and genes whose promoters are
bound by 20 TFs (rows). P values, hypergeometric test (purple: significant correlation; white: no correlation).
See also Figure S5 and Table S5.Second, we used two complementary approaches to identify
the substrates downstream of MYD88-associated kinases,
which remain poorly characterized. Perturbation approaches fol-
lowed by phosphoproteomics have proven useful in determining
functional pathway components downstream of a given network
node (Bodenmiller et al., 2010; Chevrier et al., 2011). We
measured the impact of four knockout (KO) models (Myd88/,
Myd88//Ticam1/, which abrogates all TLR4 signals),
Irak2/ and Irak4/) on the DC phosphoproteome upon LPS
stimulation for 30 min (Figures 6C and 6D). To stringently eval-
uate KO effects on the LPS-dependent DC phosphoproteome,
we focused on the 1,628 phosphositesmapping onto 990 unique
proteins that were differentially regulated in both (1) LPS-treated
wild-type DCs at 30–45 min (time course data; Table S1) and (2)
Myd88//Ticam1/ DCs compared to wild-type (Table S6).
Out of these 1628 phosphosites, a third (38.1%, 621/1,628)
were only affected by Myd88//Ticam1/ double deletion,
whereas the remaining sites were affected by both double and
single mutants: 45.6% (742/1628) for Irak4/, 31.1% (506/
1628) for Myd88/, and 8.1% (132/1,628) for Irak2/. These
numbers agree with the essential role of IRAK4 in TLR signaling
(Picard et al., 2003; Suzuki et al., 2002) and the partially redun-
dant function of IRAK2 with IRAK1 (Kawagoe et al., 2008).
Furthermore, these 990 Myd88/Ticam1-dependent phospho-
proteins captured 32.6% (46/141) of the canonical TLR proteins,
including known phosphosites such as TBK1 S716 and JUN
S63/S73 downregulated in Myd88/ and Irak4/ cells, IRF32860 Cell Reports 19, 2853–2866, June 27, 2017S379 impacted upon double KO only, or MAPK9 T183/Y185 by
MYD88- and TRIF-dependent pathways (Figure S6B).
To complement this genetic approach, we developed a large-
scale in vitro kinase (IVK) assay using recombinant kinases
IRAK4, TBK1, and IRAK2 mixed with native protein lysates
from SILAC-labeled DCs followed by phosphoproteomics (Fig-
ure 6E). We identified a total of 967 phosphosites upregulated
by IRAK4, 325 by TBK1, and 201 by IRAK2, which included sites
also upregulated in LPS-treated DCs: 55 out of 967 (5.7%) for
IRAK4 and 62 out of 325 (19.1%) for TBK1 (Figures 6F, 6G,
and S6C; Table S6). These results suggest that some of the
phosphosites identified by IVK are likely to be physiologically
relevant, although others might be due to off targets effects
(e.g., activation of secondary kinases, or proximity with proteins
in solution that would not exist in cells).
An IntegratedModel Reveals Signaling-to-Transcription
Paths across the TLR4 System
Lastly, we sought to combine ourmeasurements on physical and
functional interactions into an integrated model of signaling-to-
transcription relationships in the TLR4 system (Figure S7A). We
used a network-based approach that relies on three main steps
(Figure 7A). First, we assembled a ‘‘background’’ network of
92,610 protein-protein and 5,533 kinase-substrate interactions
from public repositories and 43 protein-protein and 230 ki-
nase-substrate interactions identified from this study using
DCs (Table S7). Second, we assigned weights to the edges
A B
C E
D F
G
Figure 6. Physical and Functional Prote-
omics Assays Pinpoint Binding and Phos-
phorylation Events Downstream of the
Myd88 Adaptor and Associated Kinases
(A and B) Affinity purification followed by prote-
omics. Shown are dot plots of SILAC ratios for
proteins identified in DCs overexpressing V5-tag-
gedMYD88 (A) or IRAK2 (B). Cells were stimulated
with LPS for 30 min and protein complexes puri-
fied using anti-V5 antibodies coupled to magnetic
beads. Each axis represents an independent
experiment.
(C) Diagram depicting our experimental approach
for measuring the impact of gene KO on the TLR4-
regulated phosphoproteome of mouse BMDCs.
(D) Phosphoproteomics in KO cells. Left: heatmap
for SILAC ratios of phosphosites (rows) in four KO
models (columns) at 30 min after LPS stimulation
compared to control wild-type cells, as indicated
(gray, missing values). Middle: phosphosites with
significant up- or downregulation in KO versus WT
(light brown). Right: phosphosites belonging to
known TLR proteins (black).
(E) Diagram depicting our experimental approach
for large-scale in vitro kinase assays using native
protein lysates from BMDCs and phosphopro-
teomics.
(F and G) In vitro kinase (IVK) assay followed by
phosphoproteomics. Shown are scatterplots of
SILAC ratios of phosphosites identified using the
purified kinases IRAK4 (F) and TBK1 (G). Light
gray, all data points; dark gray, phosphosites with
FDR < 0.1 in IVK; red, phosphosites with FDR < 0.1
in both IVK and cells stimulated with LPS, which
highlights the overlap between IVK and phos-
phoproteome measurements on stimulated cells
(denoted as IVK + cells). Gene names at the bot-
tom right of each plot indicate known TLR com-
ponents with the number of phosphosites in
parenthesis.
See also Figure S6 and Table S6.(i.e., protein-protein and kinase-substrate interactions) and no-
des (i.e., signaling or transcriptional regulators) of the back-
ground network to create a ‘‘weighted’’ interaction network
based on the phosphorylation changes driven by LPS stimula-
tion and specific kinases (based on KO and IVK data). Third,
we searched the weighted network for biochemical paths linking
the 29 phosphoproteins/signaling regulators or ‘‘seed nodes’’ to
transcriptional regulators or ‘‘target nodes.’’ To test the validity
of this integrative algorithm, we quantified its performance in
retrieving known seed-target relationships between canonical
TLR pathway components using receiver-operator characteristic
(ROC) curves. In the high precision regime, using a weighted
network outperformed methods that used the background inter-
action network or phosphorylation data alone. For example, at a
false positive rate (FPR) of 0.001, the weighted network methodCell Reyielded a true positive rate (TPR) that was
3.9and10.4 timeshigher thanbackground
network and ‘‘phosphorylation only’’ ap-
proaches, respectively (Figure S7B). Thus,our network-based approach correctly identified known signaling-
to-transcription relationships between canonical TLR pathway
components thanks to the information collected using DCs in this
study.
Next, we searched for biochemical paths connecting the 29
signaling regulators highlighted above as ‘‘seeds’’ (Figure 5A)
and the 782 TFs detected by mass spectrometry in bone
marrow-derived dendritic cells (BMDCs) as ‘‘targets’’ (Table S1).
We identified 420 significant relationships between 27 out of 29
seed(except for seed DMXL2 and RAB3IL1) and 95 out of 782
target nodes (p < 0.0005, FDR < 0.05), whereas only 12 relation-
ships linking 7 seeds to 11 targets can be foundwithout integrating
our DC-specific datasets with publicly available interactionswithin
our algorithmic framework (Figure 7B; Table S7). Each signaling
node reached between 51 (TBK1) and 3 (ARHGEF11) TFs, for anports 19, 2853–2866, June 27, 2017 2861
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Figure 7. An Integrative Analysis Reveals Known and Candidate Signaling-to-Transcription Paths and Helps Parse the Effects of Myd88 and
Associated Kinases in the TLR4 System
(A) A computational framework for integrative analysis of the functional and physical proteomics datasets collected in this study (from left to right). A background
interaction network is assembled using database and local data, nodes and edges are scored based on experimental evidence from this work, and statistically
significant relationships determined by bootstrap analysis.
(B) Cumulative number of significant relationships (bootstrap p value < 0.0005, FDR < 0.05) identified between seed nodes (29) and any of the transcriptional
regulators detected in BMDCs (782 possible target nodes in total) using background network (dark gray) and weighted network (light gray) methods.
(C) Total number of relationships linking seeds (29) and known TLR transcription regulators (14) for background network (dark gray) and weighted network (light
gray) methods.
(legend continued on next page)
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average of 14.5± 11.6 SD. TFs via 1.5± 0.7 SD intermediate nodes
(FigureS7C). Importantly, these signaling-to-transcription relation-
ships captured 11 out of the 14 canonical TLR TFs and 8 out of 20
of the TFs whose binding sites were compared to knockdown ef-
fects (Figures 5B, 7C, and 7D). Furthermore, 49% (47/95) of the
TFs were both upregulated at the phosphorylation level upon
LPS stimulation and downregulated inMyd88//Ticam1/ cells.
Overall, each of the three modules identified based on co-pheno-
types upon knockdown (Figure 5) appeared to be biochemically
linked to similar downstream TFs (Figure 7D).
We asked which intermediate nodes were most central be-
tween seed and target nodes (i.e., most connected to target
TF nodes). For the 420 significant relationships linking the 27
seed and 95 target nodes, we ranked the top 25 intermediates
present across each of our three modules (Figure 7D), which
lead to a total of 60 non-overlapping intermediate nodes that
included 16 canonical TLR pathway components (Figures 7E
and 7F). These 60 intermediate nodes displayed various levels
of specificity across the three modules identified above, with
for example IRAK4 being central to module II (i.e., connected
to a relatively high number of nodes), whereas MAPK8 (JNK)
and MAPK14 (P38) were more connected across modules I
and III, respectively. Other nodes appeared shared between
modules such as AKT1 for I and III or TAB2 for I, II, and III.
Thus, intermediate nodes display both specific and shared roles
across the regulatory modules of the TLR4 pathway, which likely
reflects crosstalk within pathways leading to the regulation of
overlapping sets of target genes.
To gain insights into how signal is distributed downstream of
TLR4, we asked how the 420 seed-target relationships identified
here were affected by the four KO strains used in this study (Fig-
ure 6D). We quantified how many of the nodes (seed, intermedi-
ate, and target) present in each of the 420 seed-target pairs were
impacted at their phosphorylation level by KO. 391 out of the 420
pairs were significantly affected by Myd88//Ticam1/, and
261 out of these 391 pairs were also impacted by Myd88/,
Irak2/, and/or Irak4/, leading to four clusters of effects: (1)
double KO only or together with (2) IRAK4 alone, (3) IRAK4 and
MYD88, or (4) IRAK4, MYD88, and IRAK2 (although to a lesser
extent) (Figure 7G). Interestingly, a large fraction of TLR4 signals
were impacted by MYD88 deletion, as expected, but IRAK4 was
responsible for broader effects despite the presence of IRAK4
and MYD88 in the same complex. Seed-target pairs that were
impacted by double-KO cells, but not MYD88 KO cells, are likely
to be important for TRIF-dependent signaling (i.e., module II).
Overall, this quantitative measurement of KO effects on
signaling-to-transcription paths provides additional information
on how signal is transmitted and partitioned from MYD88 and(D) Significant relationships (420 pairs) found between 29 seeds (columns) and 95
(columns) in light green (I), purple (II), and orange (III). Transcriptional regulators wi
versus WT and in time series are indicated on the right (light brown). P values, b
(E) An interaction network connects 27 seeds (blue) to 95 transcriptional regulators
centrality measure (see Experimental Procedures).
(F) Centrality score of the top 60 intermediate nodes across the three modules fr
(G) t-distributed stochastic neighbor embedding (t-SNE) analysis of the effects of g
the paths mediating the seed-transcriptional regulator relationships identified in
Ticam1/ (gray dots). The effects of Irak4, Myd88, and Irak2 on these paths are
See also Figure S7 and Table S7.some of its kinase partners to downstream signaling and tran-
scriptional regulatory layers.
DISCUSSION
We established an integrative framework to dissect signal prop-
agation in the TLR system using data spanning both signaling
and transcriptional regulatory events. Previous studies have
connected paths within networks largely using protein-protein
interaction or phosphorylation data alone or in conjunction with
one to two different types of experimental data (Gitter et al.,
2013; Huang and Fraenkel, 2009; Huang et al., 2013; Terfve
et al., 2015). This study provides a proof-of-principle example
of the power of integrative analyses that take into account regu-
latory layers not typically studied in conjunction, from phosphor-
ylation dynamics to relationships between kinases substrates to
proteins forming complexes or binding to DNA to gene regula-
tion. In future work, it will be crucial to take into account addi-
tional regulatory layers such as the spatial distribution of proteins
(Brubaker et al., 2015), other PTMs and their enzymes (e.g., ubiq-
uitination, acetylation) (Mertins et al., 2013), and post-transcrip-
tional modifications (RNA) or translational control events.
The observations that AP1AR, its binding partner PICALM,
and SAMHD1 might play a role in pro-inflammatory signaling
will require future mechanistic studies. Interestingly, both
AP1AR and its binding partner, PICALM, interact with clathrin
adaptor proteins (Maritzen and Haucke, 2010; Miller et al.,
2015), suggesting a link between the TLR4-MYD88 pathway
and intracellular vesicle transport regulation that is reminiscent
of the TLR4-TRIF axis (Kagan et al., 2008). In addition, previous
work linked the Ap1ar locus to TNF production by DCs triggering
colitis (Ermann et al., 2011), which further support our results on
the role of AP1AR in pro-inflammatory signaling. The other
candidate regulator reported here, SAMHD1, is best character-
ized in viral restriction (Ballana and Este´, 2015), but it also plays
a role in processes such as TNF-mediated pro-inflammatory
signaling in fibroblasts (Liao et al., 2008), cell cycle (Pauls
et al., 2014), or DNA damage (Clifford et al., 2014) and in disease
such as AGS (Crow and Manel, 2015) and cancer (Schuh et al.,
2012). LPS regulated both known and previously unrecognized
phosphosites on SAMHD1 such as T634, mouse ortholog site
for the known human T592 regulatory site targeted by CDK2
(Pauls et al., 2014), or T52 found in the poorly characterized
SAM domain and that was regulated in a MYD88-dependent
manner. Taken together, these observations provide valuable in-
formation for future mechanistic investigations.
The multi-layer datasets reported here will be useful for
further analyses, mining and hypothesis-generating purposestranscriptional regulators (rows). Modules from Figures 3B and 5A are shown
th phosphosites with significant up- or downregulation inMyd88//Ticam1/
ootstrap (purple).
(red) through the top 60 intermediate (yellow) nodes that were ranked based on
om (D).
ene KO (data from Figure 6D) on the phosphorylation levels of nodes present in
(D). Shown are all of the 391 out of 420 relationships affected by Myd88//
overlaid in orange, blue, and yellow, respectively.
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on additional candidate regulators, from the protein to the phos-
phosite level. First, many of the 131 phosphoproteins selected
for genetic screening had little to no effect on gene expression.
While poor knockdown efficiency and functional redundancy
can likely explain some of these cases, measuring the effects
of perturbing these proteins on other aspects of DC biology
such as motility or antigen presentation might help uncover
important mechanisms. Second, we focused our targeted
screen for regulators of gene expression on enzymes and their
regulators, but screening additional molecular functions is likely
to uncover additional regulators. For example, 24 phosphopro-
teins downregulated between 180 and 240 min after LPS stimu-
lation are involved in RNA binding and include the known
pathogen-sensing regulators Ddx21, Ddx3x, or Adar and a host
of potential candidates for this nascent area in TLR biology
(Anderson, 2010).
Lastly, it will be critical to build upon this work to systematically
identify functional phosphosites and their matching kinases. Our
study correctly identified many phosphosites of canonical TLR
components or other pathogen-sensing pathways such as
NLRC4 S533, which is a key site for host immunity (Qu et al.,
2012). Our large-scale IVK assay uncovered many known and
candidate substrates that will be important to validate using
in vivo chemical genetics approaches (Allen et al., 2007) and
shorter timescales to increase confidence about substrate spec-
ificity as shown in bacteria and yeast (Kanshin et al., 2015;
Skerker et al., 2008). Thus, future research on screening func-
tional phosphosites using site-directed mutagenesis will help
to reveal phosphorylated residues with functional significance
and potential therapeutic value.
EXPERIMENTAL PROCEDURES
Cells
Bone-marrow-derived DCs were generated from 6- to 8-week-old female
C57BL/6J (The Jackson Laboratory), Ap1ar/ (Maritzen et al., 2012),
Samhd1/ (Rehwinkel et al., 2013),Myd88/,Myd88//Ticam/, Irak2/,
Irak4/mice. All stimulations were performed using ultra-pure E. coliK12 LPS
(Invivogen) at 100 ng/mL. For shRNA knockdowns, high-titer lentiviruses ex-
pressing shRNAs were used to infect bone marrow cells as previously
described (Chevrier et al., 2011).
mRNA Measurements
Total or poly(A)+ RNA was extracted and reverse transcribed prior to qPCR
analysis with SYBR green (Roche) in triplicate with Gapdh for normalization.
For mRNA counting, 5 3 104 bone-marrow-derived DCs were lysed in RLT
buffer (QIAGEN) with 1% b-ME (beta-mercaptoethanol). 10% of the lysate
was used for mRNA counting using the nCounter Digital Analyzer (NanoString)
and a customCodeSet constructed to detect a total of 267 genes (including 16
control genes whose expression remain unaffected by TLR stimulation). To
determine significantly affected signature genes, a fold-change ratio is
computed for each pairwise comparison of a knockdown sample versus a
set of control samples (i.e., non-targeting shRNA; at least ten per experimental
batch).
Affinity Purification followed by Mass Spectrometry
Analysis of interaction partners of V5-tagged proteins (MYD88, IRAK2 and
AP1AR) was performed using a single-step purification procedure as pre-
viously described (Hubner and Mann, 2011), with several modifications.
Peptide samples were analyzed on a Q Exactive mass spectrometer
(Thermo Fisher Scientific), and mass spectra were processed as described
above.2864 Cell Reports 19, 2853–2866, June 27, 2017Large-Scale Phosphoproteome and Proteome Analyses
For temporal phosphoproteome analysis, BMDCs grown in SILACmedia were
stimulated with LPS and lysed and processed for enrichment of phosphopep-
tides using strong cation exchange chromatography (SCX)/IMAC (immobilized
metal affinity chromatography) as described previously (Chevrier et al., 2011).
For IVK and KO phosphoproteome analysis, peptide samples were separated
by basic reversed-phase (RP) prior to IMAC enrichment as described previ-
ously (Mertins et al., 2013). IVK reactions were performed with recombinant ki-
nases for IRAK2, IRAK4, or TBK1 on SILAC-labeled native cell lysates from
DCs. For proteome analysis, total peptides were separated into 12 fractions
using an Agilent 3100 Offgel fractionator. Peptide samples were analyzed on
LTQ Orbitrap, LTQ Orbitrap Velos, or Q Exactive mass spectrometer (Thermo
Fisher Scientific). To identify and quantify peptides, mass spectra were pro-
cessed with the Spectrum Mill (Agilent Technologies) and the MaxQuant
(version 1.2.2.5) software packages (Cox andMann, 2008). Details on differen-
tial expression, clustering, pathway enrichment, and network analyses are in
the Supplemental Experimental Procedures.
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